333 related articles for article (PubMed ID: 31376820)
1. The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.
Lu X
Curr Cancer Drug Targets; 2019; 19(11):863-876. PubMed ID: 31376820
[TBL] [Abstract][Full Text] [Related]
2. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
[TBL] [Abstract][Full Text] [Related]
3. Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1.
Singh N; Ecker GF
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695141
[TBL] [Abstract][Full Text] [Related]
4. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
Yan R; Zhao X; Lei J; Zhou Q
Nature; 2019 Apr; 568(7750):127-130. PubMed ID: 30867591
[TBL] [Abstract][Full Text] [Related]
5. Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B
Taslimifar M; Faltys M; Kurtcuoglu V; Verrey F; Makrides V
J Cereb Blood Flow Metab; 2022 Jan; 42(1):90-103. PubMed ID: 34427144
[TBL] [Abstract][Full Text] [Related]
6. Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol.
Dickens D; Chiduza GN; Wright GS; Pirmohamed M; Antonyuk SV; Hasnain SS
Sci Rep; 2017 Mar; 7():43580. PubMed ID: 28272458
[TBL] [Abstract][Full Text] [Related]
7. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
[TBL] [Abstract][Full Text] [Related]
8. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.
Lee Y; Wiriyasermkul P; Jin C; Quan L; Ohgaki R; Okuda S; Kusakizako T; Nishizawa T; Oda K; Ishitani R; Yokoyama T; Nakane T; Shirouzu M; Endou H; Nagamori S; Kanai Y; Nureki O
Nat Struct Mol Biol; 2019 Jun; 26(6):510-517. PubMed ID: 31160781
[TBL] [Abstract][Full Text] [Related]
9. The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health.
Scalise M; Galluccio M; Console L; Pochini L; Indiveri C
Front Chem; 2018; 6():243. PubMed ID: 29988369
[TBL] [Abstract][Full Text] [Related]
10. [Drug Discovery Targeting an Amino Acid Transporter for Diagnosis and Therapy].
Wiriyasermkul P; Moriyama S; Kongpracha P; Nagamori S
Yakugaku Zasshi; 2021; 141(4):501-510. PubMed ID: 33790117
[TBL] [Abstract][Full Text] [Related]
11. The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer.
Häfliger P; Charles RP
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100853
[TBL] [Abstract][Full Text] [Related]
12. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.
Kanai Y
Pharmacol Ther; 2022 Feb; 230():107964. PubMed ID: 34390745
[TBL] [Abstract][Full Text] [Related]
13. LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.
Zur AA; Chien HC; Augustyn E; Flint A; Heeren N; Finke K; Hernandez C; Hansen L; Miller S; Lin L; Giacomini KM; Colas C; Schlessinger A; Thomas AA
Bioorg Med Chem Lett; 2016 Oct; 26(20):5000-5006. PubMed ID: 27624080
[TBL] [Abstract][Full Text] [Related]
14. L-Type amino acid transporter 1 as a target for drug delivery.
Puris E; Gynther M; Auriola S; Huttunen KM
Pharm Res; 2020 May; 37(5):88. PubMed ID: 32377929
[TBL] [Abstract][Full Text] [Related]
15. Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).
Chien HC; Colas C; Finke K; Springer S; Stoner L; Zur AA; Venteicher B; Campbell J; Hall C; Flint A; Augustyn E; Hernandez C; Heeren N; Hansen L; Anthony A; Bauer J; Fotiadis D; Schlessinger A; Giacomini KM; Thomas AA
J Med Chem; 2018 Aug; 61(16):7358-7373. PubMed ID: 30048132
[TBL] [Abstract][Full Text] [Related]
16. Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation.
Napolitano L; Galluccio M; Scalise M; Parravicini C; Palazzolo L; Eberini I; Indiveri C
Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):727-736. PubMed ID: 28088504
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the LAT1 in primary human trophoblast cells increases the uptake of essential amino acids and activates mTOR signaling.
Rosario FJ; Urschitz J; Powell TL; Brown TL; Jansson T
Clin Sci (Lond); 2023 Nov; 137(21):1651-1664. PubMed ID: 37861075
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of
Lee KE; Kang YS
J Biomed Sci; 2017 May; 24(1):28. PubMed ID: 28490336
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2.
del Amo EM; Urtti A; Yliperttula M
Eur J Pharm Sci; 2008 Oct; 35(3):161-74. PubMed ID: 18656534
[TBL] [Abstract][Full Text] [Related]
20. Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1).
Ylikangas H; Malmioja K; Peura L; Gynther M; Nwachukwu EO; Leppänen J; Laine K; Rautio J; Lahtela-Kakkonen M; Huttunen KM; Poso A
ChemMedChem; 2014 Dec; 9(12):2699-707. PubMed ID: 25205473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]